Health Care Weekly: Teva’s Korlym Generic Competed Freely, Corcept Says; BCBS Cross Allocated Market Among Subsidiaries, Licensees, Michigan AG Claims; Alignment Health Sues CMS Over Star Ratings

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Corcept says Teva’s exclusive dealing claims fail. • Michigan AG accuses BCBS of anticompetitive market allocation. • CMS star ratings announcement triggers litigation.

Published on Oct 14, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.